Clinical Trial Update: Mix Vaccine for Metastatic Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a mixed vaccine for metastatic kidney cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Mixed vaccine

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Metastasis From Malignant Tumor of Kidney (Disorder), Reaction - Mixed Vaccine | Phase 1, Phase 2 | Status: COMPLETED